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Some of the simplest sphingolipids, namely sphingosine, ceramide, some closely related molecules (eicosasphingosine, phytosphingosine), and
their phosphorylated compounds (sphingosine-1-phosphate, ceramide-1-phosphate), are potent metabolic regulators. Each of these lipids modifies
in marked and specific ways the physical properties of the cell membranes, in what can be the basis for some of their physiological actions. This
paper reviews the mechanisms by which these sphingolipid signals, sphingosine and ceramide in particular, are able to modify the properties of
cell membranes.
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Sphingolipids have long been known as cell components.
Their name was given by J.L.W. Thudichum in 1884, because
of their enigmatic nature. In the second half of the past century,
when the basic lipid metabolic pathways were unraveled, the
catabolic and biosynthetic interrelations of sphingolipids
became clear. In particular, ceramide and sphingosine were
found to be intermediates in the metabolism of the more com-
plex phospho- and glycosphingolipids [1,2]. More recently,
with the discovery of the sphingolipid signalling pathway [3,4]
the interest in these lipids was renewed. Very soon ceramide,
and then sphingosine and other related compounds became
established as lipid second messengers, or metabolic signals
(see reviews in [5,7], and companion papers in this Special
Issue).
At the time of the discovery of sphingolipid signalling very
little was known of the properties of these lipids in membranes
(for a review see [8]). Data for the simplest of these molecules,
and also the most potent from the point of view of signalling,
sphingosine and ceramide, were not available. The first detailed
studies on the behavior of sphingosine in membranes were
carried out by the groups of Gómez-Fernández and Kinnunen
[9,10]. As for ceramide, Logfren and Pascher [11] and Maggio
et al. [12] had performed some Langmuir balance measure-
ments, and Pascher [13] had indicated in passing in an early
paper the possibility that ceramides could perturb membrane
permeability. Our own studies on ceramides started in 1996,
precisely with the description of ceramide ability to permeabi-
lize lipid bilayers [14].
At present there is a significant collection of data to allow a
detailed description of the membrane properties of sphingosine
and ceramides, and novel data on related sphingolipids are ex-
pected to appear soon. The present paper reviews the most
relevant data in this lively area.Fig. 1. Molecular structures2. Chemistry of sphingosine and ceramides
2.1. Structures
The basic building block of sphingolipids is sphingosine, (2S,
3R, 4E)-2-amino-4-octadecene-1,3-diol in current systematic
nomenclature. According to an older, but extensively used,
notation, its configuration is D-erythro-trans (Fig. 1). Other
sphingosine-related molecules are also found in sphingolipids
instead of the parent compound, for example the saturated
dihydrosphingosine, or the saturated phytosphingosine (contain-
ing a third OH group in C4). The C1-phosphate ester of
sphingosine is also an important molecule, commonly denoted
as sphingosine-1-phosphate (Fig. 1).
Ceramides are N-acylsphingosines, and their C-1 phosphory-
lated forms, the ceramide-1-phosphates, are also known to exist
in cell membranes (Fig. 1). Ceramides have been found in nature
with fatty acids containing from 2 to 28 carbon atoms, either
saturated or monounsaturated, in some cases containing an OH
group in either C′2 (α-hydroxy fatty acids) or in the terminal
carbon atom (ω-hydroxy fatty acids). Occasionally, a second
fatty acid can be esterified to an OH group of sphingosine or
related base. Ceramides constitute the hydrophobic backbones
of all the complex sphingolipids: sphingomyelin, cerebrosides,
gangliosides, etc. whose properties are discussed in the com-
panion papers of this review [15,16]. Free ceramides are only
found in large amounts in the skin stratum corneum [17]. They
exist in much smaller proportions in cell membranes, in which
they occur primarily as intermediates in the metabolism of the
more complex sphingolipids, and where they play an important
role in cell signalling [5,7]. The reader interested in ceramides in
the context of lipid metabolism may consult Kanfer [2],
Futerman [18], Mathias et al. [19], and Kolter et al. [20]. For a
review on ceramides in natural lipids the reader is referred to
Wiegandt [1] and Hakomori [21].of simple sphingolipids.
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crystal structure of N-tetracosanoylphytosphingosine, the first
ceramide to be examined with that technique. In the triclinic
crystal, the chains form an angle of 101°, so that the polar group
is located in the apex of a V-shaped molecule. The molecules are
linked together by one intra- and three intermolecular hydrogen
bonds. As shown later by Pascher and Sundell [23], the presence
of a dihydroxy fatty acid leads to a rather different overall
appearance. N-(2D,3D-dihydroxyoctadecanoyl)-phytosphingo-
sine molecules are almost fully extended in the unit cell, packing
alternatingly with antiparallel orientation in single layers. The
polar groups of the molecules, in this case including the two
additional OH groups of the fatty acid, form an extensive net-
work of hydrogen bonds. It should be noted, however, that both
ceramides share, between them and with cerebrosides and
phospholipids, a number of basic conformational features, and
only differ with respect to a few torsion angles that are respon-
sible for the overall apparent differences (Fig. 2) [24].
Li et al. [25] have established a number of interesting
conformational features of ceramides by NMR spectroscopy.
Ceramide was studied in diluted organic solutions that contained
measured amounts of water. Their interpretation of the spectral
trends points to a unique conformational arrangement adopted
by the hydrophilic moiety of ceramide, regardless of acyl chain
length. A network of cooperative H-bonds that involves the OH
and NH groups of ceramide, as well as two water molecules,
delineates a structural motif that is maintained even under
conditions of complete hydration. The amide proton NH is
donated to the OH groups on carbons C1 and C3 of the
sphingosine backbone. The authors note, however, that some
of these conformational features may differ from those adopted
by ceramide in a bilayer arrangement.
Determining which of the structural features of sphingosine,
ceramide, and their derivatives are essential for biological
activity is still an ongoing task. In a comprehensive study of
ceramide- and sphingosine-based inhibitors of the mitochondrial
enzyme ceramidase, that cleaves the ceramide amide bond, UstaFig. 2. Comparison of the chain conformation of a ceramide containing a hydroxylated
“non-hydroxy” ceramide (24-PSp, N-tetracosanoylphytosphingosine), a cerebroside
sphatidylethanolamine). In the two latter lipids the head group has been left out. T
segment horizontally and the atoms C(1), C(3) and N [or O(2)] in the paper plane, in o
segment. Taken from Pascher and Sundell [23].et al. [26] found that, for enzyme inhibition, the sphingosine
analogue requires the C1 and C3 hydroxyl groups, the C4–C5
double bond in the trans configuration, and the NH protons.
Dihydroceramides, that do not contain the double bond, are
biologically inactive [27]. A synthetic L-threo-dihydrosphingo-
sine, with potential anticancer use, is not desaturated in the cell,
but is used instead as a precursor for the corresponding dihydro-
sphingomyelin [28]. The sphingosine double bond influences
significantly the physical behavior of ceramides in monomole-
cular films at the air–water interface [29], and increases intra-
molecular hydration/hydrogen bonding in the ceramide polar
region [25]. Interestingly, the cis configuration of the physio-
logically trans C4–C5 double bond modifies some, but not all of
the cell functions of ceramide (G. Fabrías and F.X. Contreras,
unpublished results). The length of the fatty acyl chain modifies
significantly the physical properties of the corresponding
ceramides [30–32], however in most cases short- and long-N-
acyl chain ceramides display the same physiological properties
[19,33,34]. Note however that, in a few instances, long- and
short-chain ceramides have been found to have different bio-
logical effects [35,36].
2.2. Synthesis and determination
Organic synthesis of sphingosines is usually carried out from
the “chiral pool”. Thus, carbohydrates [37,38] and amino acids,
specially serine-derived amino aldehydes and esters [39] have
been extensively used. Other approaches include the use of
chiral catalysts [40], chemoenzymatic approaches [41], as well
as a variety of methods based on relayed asymmetric induction
[42]. Milne et al. [43] have published a procedure in which the
key step is a 1,2-metallate rearrangement of a higher order
cuprate derived from an alpha-lithiated xylal derivative and
tridecyllithium. Chun et al. [44] have described two methods for
the preparation of ceramide analogues having the C4–C5 bond
of the long-chain base as part of an aromatic or heteroaromatic
system.fatty acid [h218-PSp, N-(2D, 3D-dihydroxyoctadecanoyl)-phytosphingosine], a
(Cer B, 1-β-D-galactosylceramide), and a phospholipid (DLPE, dilauroylpho-
he four molecules are arranged with the C(1)–C(2)–C(3) sphingosine/glycerol
rder to show the structural similarities of these molecules in the C(1)–C(2)–C(3)
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been achieved using thin-layer chromatography, high-perfor-
mance liquid chromatography, or mass spectrometry (see [45],
for a review). Escherichia coli diacylglycerol kinase has also
been applied in this respect, although diacylglycerol obviously
interferes. Recombinant human ceramide kinase provides in-
stead a highly specific enzymatic method for quantifying long-
chain ceramides in cellular lipid extracts [46].
3. Physical properties of sphingosine
Sphingosine was first found to have a biological effect by
Hannun et al. [47], who described protein kinase C inhibition in
human platelets caused by the simplest of sphingolipids. The
molecular parameters (molecular area, surface potential,
collapse pressure, dipole moment contribution) of sphingosine
in monolayers at the air/water interface were measured by
Perillo et al. [48]. Sphingosine behaves as a surface-active
amphiphile, with a critical micellar concentration in the 20 μM
range [49]. In the fully protonated form, at pH 6.0, pure
sphingosine exhibits a thermotropic transition centred at 30 °C.
This transition is shifted to 39 °C at pH 10 [9]. Also López-
García et al. [9,50] observed, using 31P-NMR, that sphingosine
in membranes had an apparent pKa=9.1, thus it is positively
charged under physiological conditions. Because of this,
sphingosine may interact differently with anionic and zwitter-
ionic phospholipids in membranes. In mixtures with the anionic
dipalmitoyl phosphatidylserine DPPS, sphingosine was seen to
rigidify the membranes, forming an azeotropic mixture at a
DPPS/sphingosine molar ratio of 2:1. A eutectic point was
observed at 85 mol% sphingosine in DPPS. 31P-NMR showed
the presence of a lamellar phase at DPPS/sphingosine molar
ratios lower than 1:1, whereas at higher molar ratios an isotropic
component was detected [9].
In mixtures with zwitterionic phospholipids, sphingosine
behavior was also different with the “zero curvature” lipid
dipalmitoyl phosphatidylcholine (DPPC) and with the “negative
curvature” inducer dielaidoyl phosphatidylethanolamine
(DEPE). With DPPC sphingosine increased the so-called
pre-transition temperature (Tp, the temperature at which the gel-
to-rippled phase transition occurs in certain saturated phospho-
lipids) up to 10 mol%. Higher sphingosine concentrations
abolished the pre-transition [10]. Otherwise the interaction of
sphingosine with DPPC was rather similar than with DPPS,
sphingosine was equally found to increase the gel–fluid tran-
sition temperature, Tm, i.e. to rigidify the membranes, with an
azeotropic point at 2.3:1 DPPC/sphingosine molar ratio, and a
eutectic point at 90 mol% sphingosine. At variance with DPPS,
however, sphingosine in DPPC gave rise to lamellar phases,
according to 31P-NMR, in all the range of concentrations [50].
With DEPE, sphingosine slightly lowered the Tm main tran-
sition temperature, i.e. fluidized the bilayer, forming no
azeotropic point. A eutectic point was observed at 60 mol%
sphingosine in DEPE, with solid-phase immiscibilities being
present between 50 and 85mol% sphingosine. Unlike DPPS and
DPPC, DEPE displays a lamellar-to-hexagonal phase transition
in an easily accessible temperature range, ca. 65 °C. Sphingo-sine, at concentrations below 33 mol%, slightly shifted the
transition to lower temperatures, but the transition disappeared
abruptly at higher sphingosine proportions, so that isotropic
phases were formed instead [50].
In contrast with DPPC and other diacylphosphatidylcholines,
the Tp pre-transition temperature for dihexadecyl phosphatidyl-
choline was lowered by sphingosine, showing that the
sphingolipid destabilizes the interdigitated gel phase typical of
dialkylphospholipids [10]. In mixtures with egg phosphatidyl-
choline, a lipid whose Tm is below 0 °C, the presence of
equimolar sphingosine shifted the main transition to 29 °C.
Measurements of surface pressures in lipid monolayers at the
air–water interface revealed that sphingosine was able to
“condense” egg phosphatidic acid monolayers, i.e. to reduce
the average area occupied by one lipid molecule [10], in
agreement with the observations of bilayer rigidification by
sphingosine.
Gómez-Fernández and co-workers have studied the influ-
ence of sphingosine on the interaction of phosphatidylserine
with Ca2+. This interaction is important in a number of
physiological processes [51]. Ca2+ abolished the gel–fluid
phase transition of DPPS at DPPS/Ca2+ molar ratios of 1:0.5 or
lower. However, DPPS/sphingosine/Ca2+ mixtures exhibited
detectable phase transitions even at 1:1:10 mole ratios. In fact,
the transition enthalpies were essentially the same for DPPS/
sphingosine equimolar mixtures in the presence and absence of
Ca2+. Calcium binding experiments using 45Ca2+ demonstrated
that sphingosine all but abolishes Ca2+ binding by DPPS at
equimolar ratios [51]. The system was further studied using IR
spectroscopy, examining Ca2+-induced dehydration due to the
very strong electrostatic interaction established between DPPS
and sphingosine. It was also found that the apparent pKa of the
DPPS carboxylate group decreased from 4.6 in pure DPPS to 2.1
for DPPS/sphingosine equimolar mixtures [52]. The ensemble
of these results shows that sphingosine, being a positively-
charged molecule under physiological conditions, prevents the
binding of cations such as Ca2+ through electrostatic charge
neutralization.
Because of its cationic nature at neutral pH, sphingosine has
been used in the preparation of positively charged liposomes for
the study of membrane binding to a variety of macromolecules,
including DNA and enzymes. In liposomes composed of egg
phosphatidylcholine and egg phosphatidic acid (85:15, mol
ratio), the mainly electrostatically controlled binding of
adriamycin and cytochrome c was reversed upon the inclusion
of increasing contents of sphingosine [53]. Comparable results
were obtained with sphingosine/egg phosphatidic acid mono-
layer studies in which penetration of either cytochrome c or
adriamycin was progressively reduced by increasing sphingo-
sine contents in the monolayers. Mustonen et al. [53] also
studied the effects of sphingosine on phospholipase A2 activity.
Under low Ca2+ concentrations, that limit the rate of the enzy-
matic reaction, sphingosine gradually inhibited the hydrolysis of
phosphatidylcholine and at 1:6 sphingosine/PC mol ratio a
nearly complete lack of hydrolysis was evident. Franson et al.
[54] described as well the inhibition of both phospholipase A2
and phospholipase D by sphingosine. Finally, the influence of
Fig. 3. Sphingosine- and ceramide-induced efflux of vesicular aqueous contents.
LUVs were prepared, composed of SM/PE/Ch (2:1:1, mol ratio) containing
entrappedANTS/DPX. Sphingosine or ceramide in ethanol were added at time 0.
(A) Time course of efflux. (▴) Ethanol (control); (■) +10 mol% ceramide; (●)
+10 mol% sphingosine; and (○) +15 mol% sphingosine. (B) Dose–response
curves. Data at time=6000 s. (▴) Ceramide; (●) sphingosine (average values±
SD, n=3). Taken from Contreras et al. [49].
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bilayers has also been made apparent in the demonstration that
this sphingolipid promotes binding of the assembly factor P17
from bacteriophage PRD1 to lipid bilayers [55].
Kinnunen et al. [56], using a combination of fluorescence
spectroscopy, fluorescence microscopy, and differential scan-
ning calorimetry observed that binding of DNA to a bilayer
composed primarily of egg phosphatidylcholine depended
critically on the presence of sphingosine in the liposomes.
Attachment of DNA to sphingosine-containing membranes
could be reversed by the further inclusion of the negatively-
charged phosphatidic acid in the bilayers. On the basis of
these studies, Paukku et al. [57] prepared sphingosine-
containing liposomes for the in vitro transfection of DNA.
KK-1 murine granulosa cells were most efficiently transfected
with liposomes composed of phytosphingosine/dioleoyl
phosphatidylethanolamine/dioctanoylglycerol (64:31:4.8 mole
ratio). Other cell lines could also be effectively transfected
with these liposomes, but the murine Sertoli cells, MSC-1,
selectively resisted transfection by the sphingosine-containing
liposomes.
The interaction of DNA with sphingosine/phosphatidylcho-
line mixtures has been studied in more detail also by the
Kinnunen group, using the Langmuir balance. Lipid monolayers
were spread consisting of 1-palmitoyl-2-oleoylphosphatidyl-
choline (POPC) and sphingosine. Surface pressure-area iso-
therms and monolayer dipole potentials were determined as a
function of sphingosine mole fraction with and without a
charge saturating concentration of DNA in the subphase. In
agreement with previous observations [10], Saily et al. [58]
found that even low contents (5 mol%) of sphingosine in a
POPC monolayer caused remarkable film condensation (by
20% at 20 mN/m). This was accompanied by a pronounced
increase in dipole potential, suggesting that condensation
causes a reorientation of the P–N+ dipole of the POPC head-
group. The presence of DNA affected the POPC/sphingo-
sine monolayers differently, depending on the proportion of
sphingosine.
A novel, interesting property of sphingosine is its ability to
permeabilize membranes to small solutes. This was recently
shown by Siskind et al. [59] who, using electrophysiological
methods, described sphingosine “channels”, characterized by
short open lifetimes and diameters smaller than 2 nm, in planar
lipid bilayers. Sphingosine was also found to form these
channels in red blood cell membranes. This sphingosine
property has also been explored by Contreras et al. [49], who
found sphingosine-induced efflux of aqueous solutes from
liposomes and resealed ghost membranes (Fig. 3). Sphingosine
increased permeability in a dose-dependent form, between 5
and 20 mol% total lipids. The authors interpreted this effect as a
result of the bilayer rigidifying properties of sphingosine,
mentioned above. Rigidification would stabilize gel domains in
membranes, raising their melting temperatures and increasing
the transition cooperativity. Structural defects would form as a
result of the lateral phase separation of the “more rigid” and
“less rigid” domains, and these defects would be likely sites for
the leakage of aqueous solutes to the extravesicular medium.The presence of coexisting domains in the plasma membrane
makes it a target for sphingosine permeabilization.
3.1. Sphingosine-1-phosphate
This bioactive lipid was found to serve as a second messenger
for cell proliferation [60], and survival [61]. More details on its
physiological actions can be found in a companion paper in this
Special Issue [62]. Very little is known of the biophysical
properties of this lipid. Work in progress in our laboratory
indicates that pure sphingosine-1-phosphate in buffer exhibits a
low-enthalpy thermotropic order-disorder transition centered at
65.2 °C. In common with sphingosine it lowers the temperature
of the gel–fluid transition of DEPE, thus stabilizing the fluid
over the gel phase, but at variance with the non-phosphorylated
sphingolipid it clearly hinders the lamellar–hexagonal transi-
tion, stabilizing the bilayer over the inverted hexagonal
structure. This would be expected, in view of the opposite
geometries of DEPE and sphingosine-1-phosphate, the former
favouring negative monolayer curvature, and inverted hexago-
nal phases, the latter inducing positive curvature, and micelle
formation.
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Ceramides (N-acylsphingosines) have been known for
decades as intermediates in sphingolipid metabolism and as
minor membrane components [1,63]. However, their role as
powerful metabolic signals involved in many cellular events has
been discovered more recently [3,4]. The most commonly found
ceramides, that is, those with a fatty acyl chain of 16 carbon
atoms or longer, are among the least polar, more hydrophobic,
lipids in membranes. Indeed, their hydrophobicity explains their
abundance in the stratum corneum, the barrier that prevents
water evaporation through the skin [64]. Their solubility in water
is negligible. Thus, free ceramides cannot exist in solution in
biological fluids or in cytosol. In addition, long-chain ceramides
(e.g., with a fatty acid C12 or longer) belong to the category of
“non-swelling amphiphiles” [65], implying that they cannot
even give rise to micelles or other aggregates in aqueous
suspension, as do, for example, common phospholipids, glyco-
sphingolipids, surfactants, etc. Short-chain ceramides (e.g.,
N-acetyl or C2 ceramide) appear to “swell” in water, giving rise
to homogeneous dispersions [66,67], that are treated, in practice,
as solutions.
4.1. Properties of the pure ceramides
The thermotropic properties and phase behavior of anhy-
drous and hydrated pure ceramides have been examined in
detail by Shipley and co-workers. A synthetic N-palmitoyl-
sphingosine (C16 ceramide) was studied at various degrees of
hydration [68], using differential scanning calorimetry and
X-ray diffraction techniques. The fully hydrated ceramide
exhibits a complex polymorphic behavior. At room temperature,
a well-ordered metastable bilayer phase exists. Upon increasing
the temperature, an exothermic transition occurs at 64.2 °C to
form a stable bilayer phase with crystalline chain packing. The
transition produces an increased chain tilting with respect to the
bilayer normal and/or partial dehydration. Further heating
converts the crystalline phase into a disordered, melted-chain
phase, of an undefined structure, through an endothermic
transition at 90 °C (ΔH=13.8 kcal/mol). In contrast, the
anhydrous C16 ceramide shows a single, broad endothermic
transition at 95.4 °C (ΔH=10.4 kcal/mol). The complex
behavior of the hydrated ceramide is also found in more polar
sphingolipids, for example sphingomyelin or cerebroside, and
suggests hydrogen bonding of the hydroxyl groups of
sphingosine to the amide group of adjacent molecules. However
the presence of an α-hydroxy group in the fatty acyl residues
induces a simpler phase behavior, and the fully hydrated
hydroxy ceramides exhibit a single, reversible endothermic
transition between a bilayer gel and a hexagonal fluid phase
[69]. Similar results have been independently obtained by Han
et al. [70].
Phase behavior as well as intermolecular and intramolecular
interactions in hydrated ceramides have been examined by
Moore et al. [70 bis] using infrared spectroscopy. Ceramides of
natural origin have been studied, either containing or not α
fatty acids. The observed phase behavior is mostly coincidentwith the one described by Shah et al. [68,69], the differences
being probably due to the complex fatty acid composition of
the ceramides used by Moore et al. In addition, infrared
spectroscopy allows the observation of extensive hydrogen-
bonding between ceramide headgroups in the bilayer phase.
Importantly, intermolecular interactions in non-hydroxy cer-
amides occur mainly along an axis perpendicular to the bilayer
plane, while hydroxy ceramides exhibit in-plane interactions
through hydrogen-bonding. This behavior may help to explain
the phenomenon of lateral segregation of non-hydroxy
ceramides when mixed with phospholipids (see Domain
formation).
Langmuir balance studies have been very useful in under-
standing certain ceramide properties. In principle, a lipid
monolayer at the air–water interface can be obtained either by
carefully depositing the lipid (in organic solution) on top of the
aqueous surface, or else by injecting the lipid solution into the
aqueous phase. In both cases the equilibrium situation will
include a lipid monolayer at the interface. In practice, however,
when a long-chain (N-palmitoyl) ceramide in organic solution is
injected in the aqueous phase (the “subphase”) surface tension
does not vary in several hours, such is the hydrophobicity of the
ceramide, that remains presumably in the form of aggregates in
the trough [31]. However when the same ceramide is deposited
onto the water surface, a monolayer is formed, as indicated by
the decrease in surface tension detected by the balance. The
extreme hydrophobicity of ceramides, demonstrated in these
experiments, explains the very low rate of exchange of long-
chain ceramides between phospholipid vesicles (in the order of
days) [71] and the need for a ceramide transfer protein in cells
[71 bis].
Studies of bovine brain ceramides containing mainly 32%
stearic and 48% nervonic acids, in monolayers extended at the
air–water interface of a Langmuir balance, indicate that cera-
mide forms a liquid-condensed film at 24 °C with a limiting
mean molecular area of 0.40–0.45 nm2 and surface potential of
515 mV at the collapse pressure of 40 mN/m [8,12]. Similar
mean molecular areas, with collapse pressures at ca. 50 mN/m
have been measured for pure N-palmitoyl and N-nervonoyl
ceramides [72]. The compression free energy (the two-
dimensional work required to bring together the molecules
from the liquid expanded state at 2 mN/m to a closely packed
state at 35 mN/m) of bovine brain ceramides is of about 200 cal/
mol [8], significantly lower than that of the more complex
sphingolipids and phospholipids. Conversely the maximum
compressibility modulus (a quantitative measure of the state of
the monolayer, obtained from the slope of the pressure-area
curve as K=−A (δπ/δA)T, A being the molecular area at a given
surface pressure) of bovine brain ceramide has been established
at 205 [73], higher than those found for the more complex
membrane lipids, and indicating a rather condensed state of the
ceramide monolayer. Even higher maximum values of K (or
Cs−1 in the terminology of Brockman and co-workers) are found
for chemically defined ceramides, ca. 400 for N-nervonoyl-
sphingosine and ca. 700 for N-palmitoylsphingosine [72]. The
higher the value of this modulus, the lower the interfacial
elasticity [74].
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When mixed with phospholipid monolayers or bilayers,
ceramides have two main effects, they increase the molecular
order of phospholipids, an they give rise to lateral phase
separation and domain formation. Ceramides in bilayers have
the additional effects of inducing membrane permeabilization,
transbilayer (flip-flop) lipid movements, and transition to non-
lamellar phases. The effects of ceramides in mixtures with the
more complex glycosphingolipids are described in the compa-
nion review by Maggio et al. [16].
5.1. Lipid ordering effect
The degree of lipid chain order (in particular the “dynamic
order” that is usually related to bilayer fluidity) is often
estimated using the fluorescence probe diphenylhexatriene
(DPH). DPH fluorescence polarization increases with increasing
molecular order (decreasing fluidity). In fact, a natural cera-
mide (containing both α-hydroxy and non-hydroxy long-chain
fatty acids) was seen to increase acyl chain order in a dose-
dependent form in dimyristoyl phosphatidylcholine bilayers in
the fluid lamellar phase [75]. A similar effect was observed
with a chemically defined C16-ceramide in bilayers composed
of 1-palmitoyl-2-oleoyl phosphatidylcholine [76]. Moreover,
in situ generation of ceramide through the action of sphingo-
myelinase on bilayers containing phosphatidylcholine and
sphingomyelin also lead to an increased DPH fluorescence
polarization [76]. Massey [77] also observed an increase in
DPH polarization as a function of ceramide concentration in
sphingomyelin, POPC and DPPC bilayers in the fluid phase.
Addition of ceramide to DPPC and sphingomyelin bilayers,
both of which have gel–fluid phase transitions at ca. 40 °C,
increased the phase transition temperature Tm, in agreement
with the ordering effect of ceramide. Recently, Silva et al. [78]
have shown that polarization of transparinaric acid fluores-
cence in POPC fluid bilayers is much more sensitive than DPH
to the ceramide-induced ordering effect of ceramide, an increase
being detectable already at 2 mol% ceramide, and reaching a
plateau at 20 mol%. The mean fluorescence lifetime of trans-
parinaric acid also increases sharply with ceramide concentra-
tion. The increased lifetimes would in principle lead to a
decrease in anisotropy, but the rigidity imposed by the ceramide
is such that the increased rotational correlation times compensate
for the raised lifetimes [78].
A different technique, namely 2H-NMR spectroscopy, was
used by Huang et al. [79,80] to show that either bovine brain
ceramide or synthetic C16-ceramide induced large increases in
the order parameters of the acyl chains of fully deuterated
dipalmitoylphosphatidylcholine (d62-DPPC) when the latter is in
the fluid state. More recently, Hsueh et al. [81] observed using
2H-NMR that the acyl chains of d31-POPC in the fluid phase
were ordered by the presence of ceramide. Theywere also able to
detect that, under those conditions, ceramide chain ordering was
greater then that of POPC. The ordering effect of ceramides is in
good agreement with the “very rigid” Langmuir-type mono-
layers that were formed by different long-chain natural andsynthetic ceramides at the air–water interface [82], and with the
highly condensed ceramide monolayers described by Carrer and
Maggio [73]. Note however that, in mixtures with the fully
saturated DPPC, ceramide mixes almost ideally, at least at 24 °C
[73], thus no condensing effect on the phospholipid is exerted
here. Consequently there may not be a simple correlation
between lipid condensation in monolayers and lipid chain
ordering in bilayers.
5.2. Domain formation
Separation into ceramide-rich domains was first observed by
Huang et al. [79], who examined the structure of bilayers
composed of fully deuterated DPPC and bovine brain ceramide
using 2H-NMR spectroscopy. These authors observed that
addition of ceramide induced lateral phase separation of fluid
phospholipid bilayers into regions of gel and liquid–crystalline
(fluid) phases, ceramide partitioning largely into the gel phase
of d62-DPPC. Further
2H-NMR studies by Hsueh et al. [81], of
mixtures of C16:0 ceramide and d31-POPC found that gel and
liquid–crystalline (fluid) phases coexisted over a wide range of
temperatures and compositions, with domains of different
composition and physical state being present at physiological
temperatures. However, no evidence of liquid–liquid phase
separation in the fluid phase was found. A similar behavior of
long-chain ceramides has been detected in phosphatidylcholine/
phosphatidylserine mixtures [83]. The use of a pyrene-labeled
phospholipid, a fluorescent probe that is sensitive to lateral
mobility and to the local concentration of fluorophore in the
membrane, allowed Holopainen et al. [75,76] to detect cera-
mide-enriched microdomains in fluid phosphatidylcholine
membranes. A parallel kinetic study of ceramide generation
and formation of ceramide-rich domains [76] revealed that,
under conditions allowing fast ceramide synthesis, changes in
the lateral organization of the membrane took significantly
longer time to occur (one order of magnitude, under the condi-
tions of the experiment).
Domain formation by ceramides was also described by a
combination of differential scanning calorimetry and IR
spectroscopy, using natural ceramides (brain, egg) and several
synthetic phospholipids [84]. Calorimetry was used to detect
gel–fluid transitions. Different domains, when formed, “melt”
at different temperatures, so that they can be easily detected.
Veiga et al. [84] found lateral separation of ceramide-rich
domains with as little as 5 mol% ceramide. Disparity of chain
lengths between lipid species (“chain mismatch”) has been
mentioned as the origin of certain cases of lateral phase sepa-
ration [85]. However this is not the case in the present example,
because ceramides of different lengths (brain, egg) gave almost
equivalent results in phospholipid mixtures examined by
calorimetry. IR spectroscopy, together with the use of deuterated
lipids, can be applied to the resolution of the gel–fluid transition
in ceramide-rich and -poor domains. Veiga et al. [84] prepared
mixtures of deuterated phospholipid (d54-DPPC) with natural
ceramide. IR spectroscopy clearly reveals a gradual melting of
DPPC along a wide range of temperatures (covering the various
domains), while ceramide exhibits a much sharper transition,
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enriched domains [84].
Carrer and Maggio [73] have studied mixtures of bovine
brain ceramide, which contains mostly C18:0 and C24:1 fatty
acids, with DPPC, both by differential scanning calorimetry and
in lipid monolayers extended at the air–water interface. The
calorimetric results are essentially coincident with those by
Veiga et al. [84], with in-plane phase separation being hinted at
with only 1% ceramide. Measurements of surface potentials in
monolayers reveal that molecular dipole potentials may play an
important role in lateral phase separation, with favourable
ceramide-PC dipolar matching in the liquid state being one of
the local determinants for close molecular interactions, and
unfavourable matching explaining domain segregation of cera-
mide-enriched phases (see also [71]). The extensive review by
Maggio [8] contains detailed information on domain formation
in sphingolipid-based membranes.
An important observation related to domain formation by
ceramides in phospholipid bilayers comes from the studies by
ten Grotenhuis et al. [82] involving ceramides, cholesterol, and
free fatty acids, that is, the lipids believed to constitute the
stratum corneum matrix. These authors examined an extensive
series of binary and ternary mixtures of the above lipids in the
form of supported Langmuir–Blodgett monolayers. The mono-
layers were probed by atomic force microscopy. C16-ceramide
mixed well with cholesterol, but the longer-chain ceramides did
not, and lateral phase separation was observed under a variety of
conditions. The same phenomenon of in-plane separation was
described by Ferraretto et al. [86] for sphingolipids other than
ceramides, using differential scanning calorimetry. With palmi-
toylsphingomyelin bilayers containing bovine brain (long-
chain) GM1 ganglioside and cholesterol, these authors were
able to detect separate domains enriched in sphingomyelin and
cholesterol. In a recent study Chiantia et al. [87] have used a
combined approach of atomic force microscopy, fluorescence
correlation spectroscopy, and confocal fluorescence imaging to
observe gel-like ceramide-enriched domains in SM/DOPC/
Cholesterol/ceramide supported bilayers in the liquid-ordered
state.
Monolayer studies have revealed interesting aspects of
domain formation by ceramide in phospholipid monomolecular
films. Holopainen et al. [72] studied the mixing behavior of
dimyristoyl phosphatidylcholine (DMPC) and either N-palmi-
toylsphingosine (C16: ceramide) or N-nervonoylsphingosine
(C24:1 ceramide). C16:0 ceramide appears to be immiscible
with DMPC, while C24:1 ceramide and DMPC are miscible,
albeit non-ideally. In both cases fluorescence microscopy
reveals the segregation of ceramide-rich and-poor domains,
but with very different morphologies. For C16:0 ceramide the
dark, ceramide-enriched domains seen under the microscope
exhibit a complex, interconnected network with some round
domains entrapped into the bright continuum. C24:1 ceramide/
DMPC monolayers exhibit flower-like ceramide-enriched, solid
domains that do not fuse together even at high surface pressures.
Domain shape is the result of a balance between line tension and
dipole–dipole repulsion. When the former dominates, round
domains with minimum domain boundaries arise, while flower-shaped domains and networks are the result of predominant
dipole–dipole repulsion [88]. The different domain morpholo-
gies found for the two ceramides in mixtures with DMPC are
probably reflecting the different interaction between the film
constituents. In spite of the fact that observations in lipid
monolayers cannot be directly translated into phenomena
occurring in membrane bilayers, the results by Holopainen et
al. [72] suggest that different ceramide species may serve very
different biological functions, determined by their different
impact on the membrane physical properties.
A recent, detailed study of C16 ceramide/POPC interaction
in fluid bilayers [78] sheds new light on the ability of ceramides
to give rise to rigid, ordered domains under these conditions.
These authors have combined fluorescence spectroscopy and
transmission electron microscopy to construct a detailed phase
diagram for the binary mixtures of the above lipids. The phase
diagram is dominated by spherical vesicles in the fluid phase at
low ceramide concentrations and high temperatures. Lowering
temperature leads to coexisting fluid and ceramide-rich gel
phases, and eventually to coexisting POPC-rich and ceramide-
rich gel phases. At ceramide concentrations above 50 mol% a
new highly ordered ceramide-rich phase appears. Also at these
high ceramide concentrations cylindrical membranous struc-
tures with round extremities are visible under the electron
microscope, while crystalline ceramide structures are only seen
above 92 mol% ceramide. In agreement with several previous
studies, Silva et al. [78] find significant changes in membrane
properties already at 2 mol% ceramide. This, together with their
observation that ceramide-rich domains are large in size,
supports the biological relevance of these studies, considering
that ceramide-driven formation of large liquid-protein “plat-
forms” in cell membranes has been proposed to have a key role
in viral and bacterial internalization, and in the induction of cell
apoptosis by death receptors and stress stimuli [89–91].
In the apoptotic signalling pathway, ceramide is believed to
be formed as a consequence of acid sphingomyelinase acti-
vation, in response to an appropriate stimulus (see reviews in
[5,6,92]). Thus biophysical studies of domain formation in
ceramide/sphingomyelin mixtures are particularly relevant in
this context. As mentioned above, Holopainen et al. [76]
observed formation of ceramide-rich domains treating sphingo-
myelin-containing vesicles with bacterial sphingomyelinase.
Further studies form Maggio's laboratory have provided
interesting data on the subject of ceramide domains generated
by sphingomyelinase. Epifluorescence studies of sphingomyelin
monolayers being degraded by sphingomyelinase added to the
aqueous subphase, indicate in real time that formation of
ceramide initially alters surface topography by inducing phase
separation into condensed (ceramide-enriched) and expanded
(sphingomyelin-enriched) domains [93] (Fig. 4). The ceramide-
enriched phase grows steadily as the reaction proceeds at a
constant rate, up to the “percolation point”, when the condensed
domains coalesce into a continuous one that contains the now
discontinuous expanded phase. At this point the reaction rate
drops rapidly, showing that the supramolecular organization into
domains influences enzyme activity at the local molecular level.
Also significant is the observation by Fanani et al. [93] that the
Fig. 4. Time course of sphingomyelinase-driven conversion of SM to ceramide in lipid monolayers at 10 mN/m. (A–H) Representative pictures of DiLC12 fluorescence
in SM/Cer monolayers at different times of the enzymatic reaction. Dark regions in the pictures represent the formation of ceramide-enriched lipid phases with
unfavourable partition conditions for the lipophilic fluorescent probe DiIC12. Taken form Fanani et al. [93].
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reaction is different from that obtained by premixing sphingo-
myelin and ceramide in the same proportion, indicating that the
information contents depends on the manner in which the
surface was generated.
Amore detailed study of the same system, in which advanced
image-processing routines were incorporated in combinationwith time-revolved epifluorescence microscopy [94] revealed
the following sequence of events: (1) spontaneous nucleation
and circular growth of ceramide-enriched domains after
injection of sphingomyelinase into the aqueous subphase or
the sphingomyelin monolayer; (2) domain-intrinsic discrete
transitions from circular to periodically undulating shapes,
followed by a second transition toward increasingly branched
Fig. 5. Idealized temperature-composition diagram for a mixture of a
phospholipid and a long-chain ceramide in excess water. Tc is the main gel–
fluid transition of the pure phospholipid. C, ceramide-rich gel phase. Lβ,
phospholipid-rich gel phase. Lα, fluid phase.
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predominantly hexagonal domain lattices; (4) formation of
super-superstructures by the hexagonal lattices, and (5) rota-
tionally and laterally coupled domain movement before domain
border contact. Again none of these patterns could be repro-
duced when ceramide was added to sphingomyelin instead of
being generated by the enzyme. Härtel et al. [94] conclude that
sphingomyelinase induces a domain-specific packing and
orientation of the molecular dipole moments perpendicular to
the air/water interface. The observed high-level organization of
lipid domains constitutes a novel example of signal transduction
from local (nm, single molecule) to long-range (μm, domain
superstructure) scales.
Ceramide-enriched domains in sphingomyelin/ceramide
vesicle bilayers, rather than monolayers, have been described
recently by Sot et al. [95], using mainly differential scanning
calorimetry (DSC) and fluorescence microscopy. DSC data
showed for pure egg sphingomyelin a rather narrow transition
centered at 39 °C. Egg ceramide, even at low proportions (5 mol
%) had the effect of widening the phase transition, shifting it to
higher temperatures. More important, the endotherms of
ceramide-containing samples had a clearly asymmetric shape,
indicating formation of high-T melting ceramide/sphingomyelin
domains. In fact the observed overall endotherms could be fitted
to three-component endotherms, corresponding to as many
coexisting domains with different compositions. The corre-
sponding phase diagram includes a wide temperature/composi-
tion region of coexisting domains [95]. In addition, a series of
observations were carried out on giant unilamellar vesicles
(GUV) using fluorescence microscopy. The vesicles were doped
with the fluorescent probe DiIC18, that partitions preferentially
into the more fluid membrane regions. Pure sphingomyelin
vesicles appeared uniformly stained, whereas those containing
egg ceramide displayed dark areas, corresponding to rigid,
ceramide-rich domains. Increasing ceramide concentrations
caused a parallel increase in dark areas, that changed their
shape from circular to elongated or worm-like. The percolation
point for the ceramide-rich domains appeared to occur between
20 and 30 mol% ceramide, at the latter concentration the dark
domain being already continuous [95]. Interestingly, these
authors found that sphingomyelin/ceramide bilayers were
resistant to solubilization by Triton X-100 at 4 °C, the non-
solubilized residue being enriched in ceramide.
5.3. Phase behavior and non-lamellar phase formation
The lamellar region of the phase diagrams of ceramide/
phospholipid bilayers has been partially explored by different
workers [75–77,79–81,84,95,96]. More detailed phase-compo-
sition diagrams for ceramide/phospholipid binary mixtures in
excess water have been proposed for bovine brain ceramide/
DPPC [73], C16:0 ceramide/POPC [78], C16:0 ceramide/
DMPC [97], and C16:0 ceramide/DEPE [32]. In all these
cases (with the exception of Silva et al., [78]), the phase
diagrams have been constructed mainly on the basis of DSC
data, supplemented by other techniques, e.g. X-ray scattering,
31P-NMR, or electron microscopy.The overall picture that arises, for ceramide concentrations up
to ≈20 mol% (Fig. 5), is one in which, at low temperatures, in
the gel phase, ceramide hardly mixes, if at all, with the
phospholipid. Ceramide does mix with the phospholipid in the
fluid phase, but non-ideally. As a result, a region in which
various lamellar domains coexist appears at very low ceramide
concentrations, and extends toward higher temperatures as
ceramide concentrations increases. Only Silva et al. [78]
explored the region of the phase diagram corresponding to
high ceramide concentrations, and found a complex patchwork
of different crystal and gel phases. Holopainen et al. [97] studied
also phase transitions in the cooling mode, detecting very strong
hysteresis in the thermal phase behavior of ceramide containing
membranes.
Under equilibrium conditions, the disposition of lipids in cell
membranes resembles that of the lamellar phases formed by
some pure phospholipids – for example, egg phosphatidylcho-
line – in water. However, the idea that transient non-lamellar
structures may form in membranes under nonequilibrium
conditions is now widespread. Such non-lamellar structures
are indeed formed under equilibrium conditions by certain
phospholipids. One of them, dielaidoyl phosphatidylethanola-
mine (DEPE) exhibits a reversible lamellar-to-inverted hexago-
nal phase transition at 65 °C. Inverted hexagonal, together with
inverted cubic phases, are believed to be involved in processes of
membrane fusion and fission ([98,99], and references therein).
Veiga et al. [84] have analyzed the lamellar-to-inverted
hexagonal phase transition of DEPE, either pure or in mixtures
with natural long-chain ceramides, by a combination of diffe-
rential scanning calorimetry and 31P-NMR spectroscopy. Cera-
mides decrease the transition temperature, without significantly
modifying the transition enthalpy, thus facilitating the inverted
hexagonal phase formation. Additionally, 31P-NMR indicates
that, under certain conditions, lamellar and hexagonal phases
may coexist. Earlier studies by Ruiz-Argüello et al. [14] had
shown, also by 31P-NMR spectroscopy, that the presence of 10
mol% ceramide facilitated the thermotropic lamellar-to-“iso-
tropic” (non-lamellar) transition in mixtures containing phos-
pholipids and cholesterol. However, when mixed with the more
Fig. 6. Temperature-composition diagrams for (A) DEPE/Cer16, (B) DEPE/
Cer6, (C) DEPE/Cer2 mixtures in excess water. Transition temperatures were
derived from DSC thermograms. Phase structures were obtained from X-ray
diffraction and 31P-NMR, C, ceramide-rich gel phase. Lβ, DEPE, or DEPE-rich,
gel phase. Lα, liquid–crystalline, or fluid phase. HII, inverted hexagonal phase.
(●, ○) Respectively, onset and completion temperatures of the gel–fluid phase
transition. (▾, ▿) Respectively, onset and completion temperatures of the
lamellar–hexagonal phase transition. (Modified from [32]).
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chain ceramides are unable to induce non-lamellar phase forma-
tion even at high temperatures [83]. Yet in the latter system the
addition of 15% dioleoylglycerol and 15% C6-ceramide leads to
the partial conversion of the lipid into an isotropic phase, as
detected by 2H-NMR. More recently, using a combination of
DSC, 31P-NMR and X-ray scattering, Sot et al. [32] have
explored systematically the non-lamellar (inverted hexagonal, or
HII) region of the C16:0 ceramide/DEPE phase diagram. As
described above, ceramide was solubilized in fluid DEPE and
had the effect of decreasing the lamellar–hexagonal (L–H)
transition in a dose-dependent way (Fig. 6A). At ≈20 mol%
ceramide the onset of the L–H transition overlapped with the
completion of the gel–fluid transition at ≈48 °C, so that in this
region of the phase diagram (>20 mol% ceramide) no pure fluid
lamellar phase existed, and a direct gel-to-inverted hexagonal
transition was possible. Long-chain ceramides have the
propensity to stabilize inverted phase because of their geometry
[100–102].
5.4. Membrane permeabilization by ceramides
Apossible implication of ceramides inmembrane permeability
was already hinted at by Pascher in his early structural work [13].
Ruiz-Argüello et al. [14] prepared LUV composed of sphingo-
myelin, phosphatidylethanolamine and cholesterol at a 2:1:1 mol
ratio, that contained entrapped fluorescent dyes in solution. Upon
treatment with sphingomyelinase, ceramide was produced and
leakage of vesicle aqueous contents occurred in parallel. (Simul-
taneous vesicle aggregation was also observed, see below).
Leakage at various rates was also detected with other lipid
compositions based on sphingomyelin and phosphatidylethano-
lamine, and, importantly, also with fluorescent dye-loaded and
resealed erythrocyte ghosts after addition of sphingomyelinase.
Moreover vesicle efflux has been detected, only in the presence of
Ca2+, as a result of the activity of a novel phospholipase
C/sphingomyelinase, PlcHR2 from Pseudomonas aeruginosa
(L.R. Montes, unpublished). In further studies using the Bacillus
sphingomyelinase, Montes et al. [103] found that ceramide
formation in LUV loaded with fluorescein-derivatised dextrans
gave rise to the release of dextrans of molecular mass ≈20 kDa,
i.e. larger than cytochrome c. This is significant because ceramide
may act physiologically releasing cytochrome c from mitochon-
dria in the activation of apoptosis. The same authors compared
vesicle efflux caused by sphingomyelinase and that caused by
long-chain ceramides externally added to the pre-formed vesicles.
Vesicle contents efflux was observed in both cases, although the
same proportion of ceramides generated by sphingomyelinase
induces faster and more extensive efflux than when added in
organic solution to the preformed vesicles [103]. This may be
related to the different morphologies of the ceramide-enriched
domains when they are formed as a result of sphingomyelinase
action or when they arise from ceramide pre-existing in the lipid
mixture, being more branched, i.e. with a larger gel–fluid
interface, in the former case [94].
The origin of leakage under the above conditions has not been
fully explained. The addition or generation of ceramide in a pre-existing bilayer is required: neither ceramide incorporated into
the lipid composition during vesicle preparation, nor the
presence of sphingomyelinase in inactive form (e.g., in the
absence of divalent cations), would induce leakage. The pheno-
menon may be related to the generation of “islets” or micro-
domains rich in ceramide. The ceramide-rich spots would
constitute rigid, ordered microdomains in a “sea” of fluid lipids
(for the tendency of ceramides to separate into domains, see
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and disordered domains in a bilayer is akin to the one prevailing
at the Tc gel-to-fluid transition temperature of phosphatidylcho-
lines. Vesicles composed of pure DMPC or DPPC are known to
be particularly leaky at the Tc [104] and the interfaces between
ceramide-rich and -poor regions would allow leakage in
sphingomyelinase-treated bilayers. Structural defects induced
by ceramide in phosphatidylcholine bilayers were observed by
Zidovetzki et al. [105]. Alternatively, or additionally, generation
of ceramide at one side of the membrane (sphingomyelinase was
added to the preformed vesicles, so it is unlikely that it gets
inside them) will give rise to membrane rearrangements
including transbilayer (“flip-flop”) movement of ceramide to
the inner monolayer. In fact, the small polar headgroup of
ceramide, as compared to sphingomyelin, facilitates its accom-
modation in the more highly-curved, inner monolayer. Transbi-
layer movements of lipids are likely to generate discontinuities
in the membrane permeability barrier. Flip-flop movements of
enzymically-generated ceramide have also been invoked by
Holopainen et al. [76] to explain some of their results (see below
the section devoted to ceramide-induced flip-flop).
It is interesting in this context that Colombini and co-workers
[106], using mainly planar lipid bilayers and electrophysiolo-
gical detection methods, observed ceramide-induced channel
formation under conditions comparable to those used by Ruiz-
Argüello et al. [14]. Later Siskind et al. [107] found that
ceramide could actually increase the permeability of the
mitochondrial outer membrane to cytochrome c and other
small proteins. However, one debated aspect of their work is that
they propose, as the mechanism for ceramide-induced efflux, the
spontaneous formation of transmembrane channels composed of
pure ceramide with ceramide chains parallel to the plane of the
membrane. The structure, and even the existence of such chan-
nels has been challenged by other authors, although Anishkin et
al. [108] have provided support to the transmembrane ceramide
channels on the basis of molecular dynamics simulations. An
additional aspect of the work by Colombini and co-workers is
that dihydroceramide, in which the C4–C5 sphingosine bond is
saturated, and is inactive in promoting apoptosis at the cellular
level, is also little active in permeabilizing planar lipid bilayers
[106], and in fact inhibits permeabilization by ceramides [109].
5.5. Ceramide and membrane fusion
Enzymatic generation of ceramides in sphingomyelin-con-
taining large unilamellar vesicles leads to extensive vesicle
aggregation, as detected by an increase in suspension turbidity,
as well as by cryo-transmission electron microscopy of the
vesicle suspensions [14,110]. These observations were con-
firmed by Holopainen et al. [76], who could also ascertain that,
in contrast, ceramide-containing LUV (in which ceramide and
phospholipids had been mixed in organic solvent prior to
hydration and extrusion) did not show any signs of aggregation
for up to 24 h of incubation. Ruiz-Argüello et al. [14] attributed
aggregation to the localized, asymmetric generation of cera-
mide-rich patches on the vesicle surface through the action of the
enzyme. The relative dehydration and exposure of hydrophobicsurfaces at those patches would ensure aggregation, driven
mainly by hydrophobic forces.
Ruiz-Argüello et al. [14], while detecting extensive aggrega-
tion, were unable to measure any intervesicular mixing of lipids,
or of aqueous contents, that could have been correlated with
vesicle–vesicle fusion. Giant vesicles, arising from multiple
fusion events, were, however, detected by cryo-transmission
electron microscopy under slightly different conditions, namely
lower sphingomyelinase activity, by Basáñez et al. [110]. The
latter fusion phenomenon has not been studied in more detail,
but instead Ruiz-Argüello et al. [111] have described the
cooperative action of ceramide and diacylglycerol, generated in
situ respectively by sphingomyelinase and phospholipase C, to
induce aggregation and fusion of LUV containing equimolar
mixtures of sphingomyelin, phosphatidylcholine, phosphatidy-
lethanolamine, and cholesterol. Neither enzyme was able to
produce aggregation or fusion on its own. Interestingly,
microbial enzymes that are known to possess both phospholi-
pase C and sphingomyelinase activities, have been shown to
induce vesicle fusion. This is the case of the phospholipases
C/sphingomyelinases of Listeria monocytogenes [112] and
Pseudomonas aeruginosa (L.R. Montes, unpublished).
Moreover, Holopainen et al. [113] have shown microscopic
images of “endocytotic” budding of vesicles composed of phos-
phatidylcholine and sphingomyelin, upon addition of sphingo-
myelinase. The authors attributed the observed budding to the
tendency of ceramide to separate into domains, and to its nega-
tive spontaneous curvature, that leads to membrane invagina-
tion. It is clear, in summary, that ceramides can either induce by
themselves, or with the help of other molecules, the promotion of
vesicle aggregation and/or fusion.
At present, the most widely accepted mechanism for mem-
brane fusion involves the transient participation of a non-
lamellar structure, the “stalk”, a semitoroidal lipidic structure
that would allow the merger of the closest leaflets of apposed
membranes. Ceramides, because of their molecular geometry,
can be accommodated in these non-lamellar structures more
easily than lipids with larger polar headgroups, such as sphin-
gomyelin. A series of studies by Alonso, Goñi, and co-workers
(reviewed in [30]), have established a correlation between non-
lamellar phase formation and facilitation of membrane fusion.
As discussed above, ceramides promote the transition from
lamellar to non-lamellar structures, thus they could in the same
way facilitate stalk formation and membrane fusion.
Most interesting with respect to the fusogenic capacities of
ceramide observed in model systems is the data according to
which endocytotic vesicles are formed in the absence of ATP
when fibroblasts or macrophages are treated with exogenous
sphingomyelinase or ceramides. Zha et al. [114] describe how
the addition of bacterial sphingomyelinase to ATP-depleted
fibroblasts or ceramides induces the rapid formation of vesicles,
approximately 400 nm in diameter, not enriched in clathrin or
caveolin, that pinch off from the plasma membrane and go into
the cytosol. The authors speculate that hydrolysis of sphingo-
myelin on the plasma membrane causes inward curvature and
subsequent formation of sealed vesicles. This is in full agree-
ment with the biophysical data. While sphingomyelin is a lipid
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relatively small polar headgroup (“conical shape”, in the
nomenclature of Israelachvili et al. [101]) induces a “negative
curvature” [100], that is, inward curvature of the outer
monolayer of the plasmalemma. Higher ceramide concentra-
tions, particularly if localized and asymmetric, will lead to
vesicle fission by the mirror image mechanism of their
facilitation of membrane fusion [84,111]. During preparation
of this review, further evidence has been published of ceramide-
induced membrane fusion in a cellular system, namely sea
urchin cortical vesicles [114 bis].
5.6. Transmembrane (flip-flop) lipid motion
Studies by Bai and Pagano [115] using a fluorescent analog
of ceramide have provided values for the half-times of flip-flop
transbilayer diffusion of this lipid. The same study included
data for the corresponding fluorescent analogs of phosphati-
dylcholine, sphingomyelin and diacylglycerol. Ceramide flip-
flop rate had a t1/2 of about 22 min, much faster than the
phospholipids, but considerably slower than the diacylglycerol
analog (70 ms).
A study published recently by López-Montero et al. [116]
has studied ceramide flip-flop using a different approach. These
authors observed that incorporation of a very small percentage
of ceramides (approximately 0.1% total lipids) to the external
leaflet of egg phosphatidylcholine GUV suffices to trigger a
shape change from prolate to pear-shaped vesicle. By observing
the reversibility of this shape change the transmembrane
diffusion of lipids was inferred. López-Montero et al. found a
half-time for unlabeled ceramide flip-flop of less than 1 min at
37 °C. The rapid diffusion of ceramides in a phosphatidylcho-
line bilayer was confirmed by flip-flop experiments with a spin-
labeled ceramide analog incorporated into large unilamellar
vesicles.
Related studies from our laboratory [117,118] have demon-
strated, using very different procedures, that ceramides induce
generalized flip-flop motion in model and cell membranes. In a
first series of experiments [117], ceramide generation took place
in situ through the action of a sphingomyelinase added to
liposomes or cell membrane vesicles in suspension. Two dif-
ferent novel assays were developed to detect transbilayer
movement. One of the assays required the preparation of
vesicles containing a ganglioside only in the outer monolayer
and entrapped neuraminidase. Sphingomyelinase activity
induced ganglioside hydrolysis under conditions in which no
neuraminidase was released from the vesicles. The second assay
involved the preparation of liposomes or erythrocyte ghosts
labeled with a fluorescent energy donor in their inner leaflets.
Sphingomyelin hydrolysis was accompanied by fluorescence
energy transfer to an impermeable acceptor in the outer aqueous
medium.
In other experiments ceramide was added externally to pre-
formed vesicles. Flip-flop motion was demonstrated either by
the just mentioned fluorescence energy transfer assay, or by the
method of Müller et al. [119], based on the excimer-forming
capacity of the fluorescent probe pyrene, incorporated intophosphatidylcholine or phosphatidylserine analogs. When
added in organic solution to pre-formed liposomes, egg cera-
mide induced transbilayer lipid motion in a dose-dependent way.
Interestingly dihydroceramides, that are inactive from the point
of view of most ceramide physiological activities, were also
unable to promote flip-flop [118].
The origin of ceramide-induced transbilayer lipid movement
is probably the result of two different phenomena. One is the
well-known property of ceramide of facilitating the lamellar to
non-lamellar lipid phase transitions. This does not mean that,
under conditions of the experiments just described, ceramide
would bring about a phase transition so that membrane lipids
would be in the inverted hexagonal phase at the end of the
experiment. Instead, ceramide at one side of the membrane
would induce the transient formation of non-lamellar structural
intermediates, which cause the loss of lipid asymmetry in the
bilayer, i.e. the transbilayer movement of ceramide together
with other lipids. The second underlying phenomenon would be
the tendency towards mass conservation (or constancy of lateral
tension) in each membrane leaflet. When one (in our case the
outer) membrane monolayer becomes enriched in ceramides,
they diffuse (through non-lamellar intermediates) toward the
other leaflet. This is counterbalanced by lipid movement in the
opposite direction, so that net mass transfer between mono-
layers is avoided.
The observation of ceramide-induced flip-flop movement
may explain an otherwise mysterious aspect of ceramide
signalling in cell physiology, namely that sphingomyelin,
perhaps the main source of ceramide in this context, is
predominantly located in the outer monolayer of the plasma
membrane, whereas ceramide receptor proteins are intracellular.
Sphingomyelin on the outer leaflet appears to be hydrolyzed by a
secreted form of acid sphingomyelinase [89]. The resulting
ceramide, originally generated in the outer leaflet, would soon
distribute among both monolayers, thus being able to bind
intracellular proteins docking the plasma membrane inner
monolayer.
5.7. Ceramide-cholesterol interactions
In the previous sections we have concentrated on ceramide in
bilayers composed almost always of a single phospholipid. We
shall now turn our attention to the interactions of ceramide with
cholesterol. The simplest relevant system is the ceramide/
cholesterol monolayer. Scheffer et al. [120], using grazing
incidence X-ray diffraction, have shown the existence of a
crystalline mixed phase of the two components, within a range
of compositions of ceramide/cholesterol between 0:100 and
33:67 mole ratios. Between 50:50 and 70:30, the mixed phase
coexists with a ceramide crystalline phase. Above 70:30 mole
ratio, only the latter phase is found. The authors conclude that
the new crystalline mixed phase constitutes a stable, homo-
geneous arrangement of cholesterol with ceramide.
In a more complex system, namely sphingomyelin/cera-
mide/cholesterol bilayers, Massey [77] observed, on the basis
of fluorescence spectroscopic methods, that the properties of
the bilayers were dependent upon both the concentrations of
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10 mol%). In the fluid phase, both ceramide and cholesterol
separately increased acyl chain order, and their effects were
additive. More interestingly at 37 °C, near the gel–fluid
transition of sphingomyelin, ceramide and cholesterol had
opposite effects on acyl chain motion. Ceramide decreased
acyl chain motion as a result of the formation of gel-like sphin-
gomyelin/ceramide domains (“complexes” in the interpretation
of Massey), while cholesterol increased acyl chain motion by
decreasing the amount of gel phase lipid. The presence of 33mol
% cholesterol abolished the formation of gel phase sphingo-
myelin/ceramide “complexes” (domains). The presence of a
single, continuous phase in mixtures of sphingomyelin, cera-
mide and cholesterol, with a (sphingomyelin + ceramide)/
cholesterol 2:1 mole ratio was also hinted at in our studies of
sphingomyelinase degradation of sphingomyelin/cholesterol
bilayers [121].
An interesting observation has been made by London and co-
workers [122,123] that ceramide displaces cholesterol from
ordered lipid domains containing phosphatidylcholines (or
sphingomyelin) and cholesterol. These authors, following a
rather extended, if not rigorous, trend, identify fluid-ordered
lipid domains with the transient membrane domains known as
“rafts” [124]. Fluid ordered lipid domains are isolated by
centrifugation as the non-solubilized residue (“detergent-
resistant membrane”) after Triton X-100 treatment. When part
of the saturated phospholipids are replaced by ceramide in the
original vesicles, the detergent-resistant ordered domains are
found to contain ceramide instead of cholesterol.
Tight lipid packing is critical for sterol displacement by
ceramide. The authors suggest that the driving force of the event
is the hydrophobic effect that tends to minimise unfavourable
contact between the hydrocarbon groups of the small headgroup
lipids (ceramides, sterols) and the surrounding aqueous
environment. Hydrocarbon-water contact would be prevented
in ordered domains because of the capacity of certain lipids with
large headgroups (sphingomyelin, phosphatidylcholines) to
accommodate small headgroup lipids in the ordered domain
lattice. Ceramide would replace sterols with advantage from this
point of view. (See in this respect the “molecular cavity”
concept developed for ganglioside/ceramide mixtures by Carrer
and Maggio, [125]).
The results by Megha and London [122] have been obtained
with the use of detergents, with the implicit assumption that
membrane domains recovered in remnants after detergent
treatment correspond to structures that existed already in the
membranes before detergent addition. This assumption has been
criticized elsewhere [126]. However, a number of data are
available that support Megha and London's contention: (i)
Slotte and co-workers [127,128] and Chiantia et al. [87] showed
cholesterol displacement by ceramides using a detergent-free
procedure; (ii) Yu et al. [129] found essentially the same effect
using detergent but in the more complex, and relevant, system
of mammalian cells; (iii) as mentioned by Megha and London
themselves, a phenomenon of cholesterol displacement from
plasma membranes induced by sphingomyelinase activity had
been reported [130,131].5.8. Short-chain ceramides
Ceramides with an N-acyl chain shorter than 8–10 C atoms
are usually called “short-chain ceramides”. Since most naturally
occurring ceramides cannot be dispersed in water—because of
their hydrophobicity—short-chain ceramides, and particularly
N-acetylceramide, or C2-ceramide, have been extensively used
as agonists when ceramide effects had to be elicited, both in
intact cells and in cell-free systems. Short-chain ceramides form
clear dispersions in water, although the nature of the dispersion,
or of the putative molecular aggregates, have remained
unexplored until recently. In the nomenclature of Small [65],
long chain ceramides are “insoluble non-swelling amphiphiles,”
while short-chain ones are “insoluble swelling amphiphiles.” In
fact, the use of the N-acetyl derivative is not devoid of a certain
scientific pedigree. C2-ceramide is the sphingolipid equivalent
of 1-oleoyl-2-acetyl-sn-glycerol, used by Nishizuka [132]
precisely because of its solubility properties. But just because
of these physical properties, so different from those of the
“natural compound”, the use of C2-ceramide has been the object
of criticism. Some recent work from ours and other laboratories
has been devoted to compare the biophysical properties of
ceramides with different N-acyl chain length. A summary of
some of these studies may be found in Goñi et al. [133].
From the structural point of view, the NMR characterization
of ceramide structure in solution by Li et al. [25] included a
comparison of C2 and C18 ceramides. In both cases the
conformation of the polar moiety of the molecule was the same,
including the characteristic H-bond network between NH
protons and OH groups, that was not found in e.g. dihydrocer-
amide. The maintenance of the headgroup conformation
irrespective of N-acyl chain length explains that C2 ceramides
reproduce most of the long-chain ceramide signalling effects,
because their interaction with the receptor enzymes occur
probably through the polar head.
A systematic comparative study of the membrane properties
of short- and long-chain ceramides has been carried out by Sot
et al. [31,32]. Using monolayer techniques, these authors found
that C16 ceramide behaves indeed as an insoluble, non-swelling
amphiphile, not partitioning into the air–water interface, thus
not modifying for hours the surface pressure of the aqueous
solutions into which it is included, as mentioned above. By
contrast both C2 and C6 ceramides behave as soluble
amphiphiles, up to approx. 100 μM, beyond which they give
rise to large aggregates and precipitate. At low (micromolar)
concentrations, they become oriented at the air–water interface,
increasing surface pressure in a dose-dependent way up to ca.
5 μM bulk concentration. At higher concentrations, the excess
ceramide forms micelles, critical micellar concentrations of both
Cer2 and Cer6 being in the 5–6 μM range [31].
When the air–water interface is occupied by a phospho-
lipid, C2 and C6 ceramides, but not C16 ceramide, injected
into the subphase, become inserted in the phospholipid mono-
layer, causing a further increase in surface pressure. Both short-
chain ceramides become inserted in phospholipid monolayers
with initial surface pressures above 40 mN/m, which ensures
their capacity to become inserted into cell membranes whose
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of about 30 mN/m. C2 and C6 ceramides, unlike their C16
homologue, had detergent-like properties, such as giving rise to
phospholipid–ceramide mixed micelles when added to phos-
pholipid monolayers and bilayers [31]. Previous studies by
Simon and Gear [67] and by Di Paola et al. [36] described some
properties of short-chain ceramides that were not shared by long-
chain ceramides, in particular the ability of the former to perturb
cell membranes. The results by Sot et al. [31] provide a physical
basis for the observed different behavior.
In a different series of studies, Sot et al. [32] compared the
phase behavior of C2, C6 and C16 ceramides in mixtures with
DEPE. Combining DSC, X-ray scattering and 31P-NMR these
authors could build up phase diagrams for the three mixtures
(Fig. 6). The main differences between the long- and short-chain
ceramides are those of miscibility with the phospholipid, and of
geometrical shape. As discussed above, long-chain ceramides
are immiscible with phospholipids in the gel phase, while short-
chain ceramides mix quite well. The final outcome is that C16
ceramide increases the mid-point temperature of the gel–fluid
transition, and gives rise to ceramide-rich and -poor coexisting
domains, while C2 ceramide lowers the gel–fluid transition
temperature and permits only a narrow area of domain co-
existence. The geometry of long-chain ceramides is such that
they favour “negative curvature” of the monolayers (by con-
vention, the outer monolayer of a cell plasma membrane has a
positive curvature), thus they facilitate the lamellar-to-hexago-
nal phase transition. C2 ceramide has a different geometry, that
favours “positive curvature”, thus it opposes DEPE tendency to
form inverted hexagonal phases above 65 °C [32]. C6 ceramide
displays intermediate properties between the other two: it lowers
both the gel–fluid and the lamellar–hexagonal transition
temperatures of the phospholipid.
Other ceramide properties are influenced by N-acyl chain
length. In our studies of ceramide-induced solute efflux [103],
the capacity of the various ceramides to induce release of
vesicle contents decreased in the order C16>C6>>C2. How-
ever, several authors have described that C2 ceramide has the
ability to break down the membrane permeability barrier
[36,67,106]. In fact, Simon and Gear [67] observed actual
lysis of platelets at ceramide/lipid mole ratios of 0.5 (this value
was never higher than 0.1 in Montes et al. [103]). The
observation by Simons and Gear corresponds most probably to
the detergent properties of C2 ceramide, put forward by Sot et
al. [31]. Di Paola et al. [36] show that C2 ceramide can dissipate
the inner mitochondrial membrane potential, while Siskind and
Colombini [106], using electrophysiological methods, detect
pore formation in planar bilayers. In the latter two cases the
observed phenomenon is a transient increase in membrane con-
ductivity and its measurement has an inherent greater sensitivity
than that of liposomal release of contents. Thus it may well be
that permeabilization phenomena caused by C2 ceramide are so
small, in comparison with those caused by C16-ceramide, that
they become below the level of detection of fluorescence spec-
troscopy, but not of electric measurements. Siskind et al. [134]
have studied in detail C2 ceramide-dependent changes in
membrane conductance.N-acyl chain length also appears to be important for flip-flop
lipid motion. C6 and C2 were less active than egg ceramide in
promoting transbilayer lipid transfer [118]. This would be in
agreement with the long-chain (but not the short-chain)
ceramide propensity to induce inverted hexagonal phases as
the origin of flip-flop movements [32]. Finally short-chain
ceramides, as opposed to long-chain ones, do not give rise to
detergent-resistant membranes in mixtures with sphingomyelin
[95]; nor can they displace cholesterol in liquid ordered
domains [128], probably as a result of their failure to form
highly packed arrangements with saturated phospholipids, or
sphingomyelin. What is the frontier between the long- and
short-chain ceramides? In the absence of systematic studies, the
available data suggest that it is close to the N-octyl chain. Carrer
et al. [96,135] have described a phase diagram for DMPC/C8
ceramide mixtures and it resembles more the lamellar region of
the DEPE/C16 ceramide than that of the DEPE/C2 ceramide
mixture. In turn Nybond et al [128], studying the ability of
ceramides to displace sterols form liquid-ordered domains (see
previous section on ceramide-cholesterol interactions), found
that an N-acyl chain with at least 8 methylene units was required
for a ceramide to displace cholesterol. Carrer et al. [96,135]
made the interesting observation that, in DMPC/C8 ceramide
mixtures, ceramide-enriched domains may exhibit partial
interdigitation of ceramide chains in the gel phase, producing
a correlation between the organization of both leaflets. Inter-
digitation is often linked to acyl chain asymmetry [136]. It will
be worth exploring whether interdigitation occurs with
ceramides of different N-acyl chain length, and with phospho-
lipids with acyl chains longer than C14.
In view of the observed differences between short- and long-
chain differences, it should be asked whether short-chain
ceramides are acceptable as experimental analogs of their
long-chain counterparts. Our point of view has not changed
much from year 2000, when this matter was discussed at length
in Kolesnick et al. [5]. The use of C2-ceramide as an
experimental tool when an agonist is required to elicit a
ceramide-dependent response continues to be justified. “Water
soluble” ceramides may overcome the membrane barrier and,
because they possess the appropriate stereochemistry, they will
bind specific sites in the target proteins. The differences in
physical properties, mainly swelling behavior, between long-
and short-chain ceramides can explain several instances in
which, for example, sphingomyelinase and cell-permeable
ceramides have lead to different biological effects [137], or
those cases where long- and short-chain ceramides have pro-
duced diverging effects [35,138]. However, the fact that
occasional differences with the long-chain compounds are
detected should not preclude the use of C2-ceramide. Rather,
observation of such differences could provide additional clues
on the mechanism of action of ceramides at that particular level.
6. Other ceramides, and ceramide derivatives
Only a few, scattered data are available for molecules
structurally related to the sphingosine-based ceramides. It
has been mentioned in the section on ceramide structures that
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C4–C5 bond, are physiologically inactive, and they exhibit
impaired properties of H-bonding and hydration [25] and very
different interfacial properties, including looser packing [29].
Ceramides containing the C4–C5 double bond but in the cis
(non-physiological) configuration are quite different from the
point of view of the internal network of H-bonds (M.C. Yappert,
unpublished results), they insert more easily than the trans-
homologues in lipid monolayers, but they are less effective in
inducing flip-flop motion (F.X. Contreras, unpublished results).
The hydration and mesomorphic properties of N-(α-hydro-
xyacyl)-sphingosine, a kind of ceramide that occurs in the
stratum corneum of the skin, have been explored by Raudenkolb
et al. [139]. The hydrated form of this lipid has been found to
exist in a variety of phases, depending on the thermal history of
the sample. The system can only be hydrated by heating the lipid
above the melting chain transition temperature. Above this tem-
perature, the hydroxyacyl ceramide forms a hexagonal phase.
An interesting synthetic (non-natural) ceramide derivative
with a net positive electric charge has been prepared [140] and
made commercially available. Positively charged ceramides
increased inner mitochondrial membrane permeability, and
triggered release of cytochrome c, although these effects appear
to be due to activation of specific ion transporters, rather than to
a generalized loss of bilayer barrier functions.
Ceramide-1-phosphate is emerging as a novel bioactive
sphingolipid (see companion review in this Special Issue [141]).
Ceramide-1-phosphate has a variety of cell actions that appear to
be cell type-specific, e.g. it is mitogenic for fibroblasts, but rather
appears to control phagocytosis in neutrophils [142]. Ceramide
kinase, the enzyme responsible for the synthesis of ceramide-1-
phosphate, translocates during activation of transfected COS-1
phagocytic cells from the cytosol to a lipid “raft” fraction [143].
These authors measured the acyl chain order in the plasma
membrane using Laurdan fluorescence, and found that trans-
fected cells showed a higher degree of order than control cells
after stimulation. An increased order should favour membrane
fusion at the sites of phagocytosis [144]. Work in progress in our
laboratory suggests that ceramide-1-phosphate has also in
common with ceramide a marked tendency to facilitate the
transition from lamellar to inverted hexagonal phases (J. Sot,
unpublished).
7. The relevance of biophysical studies in cell biology
The question on how relevant biophysical studies, often
carried out on model systems, are to cell physiology and patho-
logy is one that worries both biophysicists and cell biologists. It
is, in fact, a question on methodology and, ultimately, a question
on how science is done, i.e. on the philosophy of science. The
question on the philosophy is indeed a question on the validity of
the reductionist approach. Biophysics, or biophysical chemistry,
admittedly takes to a limit the reductionist approach in biology.
We operate as if biology were nothing but chemistry, and
physical chemistry at that. But it has to be agreed that reduc-
tionism, as a heuristic tool, is at the very essence of molecular
biology, and there is no reason to dismiss it at this point.From a more down-to-earth point of view, the validity of
biophysics as a methodology in the cell sciences should not be
given a definitive, general reply. Methods are good as long as
they are not proven wrong, and all of them should be perma-
nently questioned. The biophysical approach to cell biology is
no exception. Many important things that we know about cell
membranes have been first observed, or explained, in the model
membranes: monolayers, bilayers, liposomes … (Equally, some
dubious concepts have also originated in the biophysical field).
Thus a healthy dose of skepticism will undoubtedly benefit
biophysics … as it will cell biology.
More specifically, membrane biophysical studies are often
criticized on the basis of the unrealistic lipid compositions
employed. What is the meaning of preparing liposomes (or
monolayers, etc.) containing e.g. 15 mol% ceramide, when
ceramide contents in cell membranes is never that high? The
answer is that the experiment is a sort of magnifying glass
applied to the “real” biological system. High ceramide (or
sphingosine, etc.) concentrations do occur in cell membranes,
only localized in space and time, i.e. in transient microdomains.
In order to understand the properties of these short-lived
membrane patches, we must reproduce them at a larger scale,
in space and time. In order to be able to detect a phenomenon, we
must have it multiplied. With many biophysical techniques, a
single membrane fusion event taking place in a cell or vesicle
population would go undetected. In a typical experimental set-
up, a veritable orgy of fusion events is induced, in order to obtain
average data of a good number of them in a reasonable time.
In the field of lipid second messengers, the anomaly has been
pointed out that lipids stay usually in the membranes, while
target proteins are known that are totally “soluble”. This matter
has been dealt with in Kolesnick et al. [5], and specifically in the
review by van Blitterswijk et al. [145]. Should these lipids be
considered as second messengers or as modulators of membrane
structure and dynamics? The answer is, certainly, both. Some
lipid second messengers, of which ceramide is a prime example,
are so hydrophobic that their cytosol concentration is negligible.
Even in this case, the possibilities of exerting physiologically
meaningful effects are manyfold: (i) lipid-induced changes in
the membrane physical properties (e.g. lipid chain order) may
influence the activity of intrinsic enzyme proteins; (ii) other
physical changes (e.g. permeabilization) may induce local
changes in ion concentrations, in turn affecting cytosolic
enzymes in the vicinity; (iii) proteins that are isolated as soluble
enzymes may in fact dock transiently to membranes, thus
binding signalling lipids; (iv) lipid transfer proteins (e.g. the
ceramide transfer protein) may bring very hydrophobic lipids to
targets that are distant from the membranes of origin. Several
examples of these possibilities can be found in the reviews
mentioned above in the paragraph.
8. Summary
(1) Sphingosine, (2S, 3R, 4E)-2-amino-4octadecen-1,3-diol,
and ceramide (N-acylsphingosine) are the simplest sphin-
golipids. They constitute the basic structure of sphin-
gomyelin, cerebrosides, gangliosides, and other complex
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and its phosphorylated derivatives are important metabolic
regulators.
(2) The simple sphingolipids, ceramide in particular, are very
hydrophobic. They can exert their physiological effects
either through changes in membrane properties or else
through binding specific target proteins that dock more or
less transiently the membrane bilayer.
(3) Sphingosine is one of the rare lipids with a net positive
charge at pH 7.4. This enables it to interact with important
negatively charged phospholipids like phosphatidylserine,
cardiolipin, or the phosphoinositides. In addition, sphin-
gosine rigidifies the bilayer lipid acyl chains and, probably
as a consequence of the latter property, it may permeabi-
lize membranes with coexisting domains of different
fluidities.
(4) Ceramides cause a variety of important changes in the
physical properties of the cell membranes: they increase
the order of the acyl chains, cause lateral separation of
domains enriched in ceramide, permeabilize lipid bilayers,
facilitate membrane fusion and fission, and induce trans-
membrane (flip-flop) lipid motion.
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